Histopathological Subtypes of Medulloblastoma According to WHO Classification (2007): An 8-year Retrospective Study
Keywords:
Medulloblastoma, large cell/anaplastic, Ki-67, WHO classification, immunohistochemical studyAbstract
Objective: To provide histopathological subtypes of medulloblastomas (according to 2007 WHO Classification of tumors of the central nervous system) that were previously diagnosed during 1998 to 2005 in Siriraj Hospital, and to characterize the immunophenotypic patterns of medulloblastomas in correlation with these subtypes.
Methods: All diagnosed medulloblastomas collected during 1998 to 2005 in the Department of Pathology, Siriraj Hospital were reviewed and classified according to WHO classification (2007) by H&E staining. Furthermore, we performed immunohistochemical studies, including synaptophysin, glial fibrillary acidic protein (GFAP), neurofilament, and Ki-67 to characterize the immunophenotypical patterns of medulloblastoma correlated with morphological variants. Statistic analyses were Tukey HSD, Mann-Whitney test, and Fisher’s exact test.
Results: Of 41 medulloblastomas, 32 cases were classic type (78.05%), 6 cases were large cell/anaplastic variant (14.63%), and 3 cases were desmoplastic variant (7.32%). This study showed significantly increased Ki-67 indices in the large cell/ anaplastic variant compared to either classic medulloblastoma or desmoplastic/nodular variant (p <0.05). There is no statistical difference in immunophenotypes of synaptophysin, GFAP, or neurofilament between each subtype.
Conclusion: According to 2007 WHO classification of tumor of the central nervous system 2007, in our study, the majority was medulloblastoma classic type, followed by large cell/anaplastic and desmoplastic/nodular variants, respectively. Statistical significance of Ki-67 indices suggests its applicable adjuvant diagnostic tool to distinguish the large cell/anaplastic variant from others.
Objective: To provide histopathological subtypes of medulloblastomas (according to 2007 WHO Classification of tumors of the central nervous system) that were previously diagnosed during 1998 to 2005 in Siriraj Hospital, and to characterize the immunophenotypic patterns of medulloblastomas in correlation with these subtypes. Methods: All diagnosed medulloblastomas collected during 1998 to 2005 in the Department of Pathology, Siriraj Hospital were reviewed and classified according to WHO classification (2007) by H&E staining. Furthermore, we performed immunohistochemical studies, including synaptophysin, glial fibrillary acidic protein (GFAP), neurofilament, and Ki-67 to characterize the immunophenotypical patterns of medulloblastoma correlated with morphological variants. Statistic analyses were Tukey HSD, Mann-Whitney test, and Fisher’s exact test. Results: Of 41 medulloblastomas, 32 cases were classic type (78.05%), 6 cases were large cell/anaplastic variant (14.63%), and 3 cases were desmoplastic variant (7.32%). This study showed significantly increased Ki-67 indices in the large cell/ anaplastic variant compared to either classic medulloblastoma or desmoplastic/nodular variant (p <0.05). There is no statistical difference in immunophenotypes of synaptophysin, GFAP, or neurofilament between each subtype. Conclusion: According to 2007 WHO classification of tumor of the central nervous system 2007, in our study, the majority was medulloblastoma classic type, followed by large cell/anaplastic and desmoplastic/nodular variants, respectively. Statistical significance of Ki-67 indices suggests its applicable adjuvant diagnostic tool to distinguish the large cell/anaplastic variant from others.
Downloads
Published
How to Cite
Issue
Section
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.